Disclosed are: a novel anti-inflammatory agent; and use of the anti-inflammatory agent.
The anti-inflammatory agent can exhibit its anti-inflammatory effect through the specific inhibition of the activation of a transcription factor NFAT.
Provided is a novel anti-inflammatory drug that exerts an anti-inflammatory effect by regulating macrophage functions.
Pyridine and pyridine N-oxide derivatives of diaryl methyl piperidines or piperazines represented by structural formula (1.0) and pharmaceutically acceptable salts thereof are disclosed, which possess anti-allergic and anti-inflammatory activity.
The compound is useful as an anti-asthmatic, anti-allergic, anti-inflammatory, or cytoprotective agent.
It is intended to provide an antiinflammatory agent and an antiinflammatory medical material having an excellent antiinflammatory effect and a high safety.
When this preventive/remedy is used together with an antiinflammatory drug, the dose of the antiinflammatory drug can be reduced.
The compounds have anti-hyperlipidimic anti-hypercholesterolemic and antiinflammatory activity.
The said composition has an characteristic of non-steroidal anti-inflammatory agent and an obvious effect of anti-inflammatory-antalgic on acute edematous inflammation and chronic granuloma .
When the anti-inflammatory agent is used in combination with a steroidal anti-inflammatory agent, a higher therapeutic effect can be produced.
More specifically, provided is a novel anti-inflammatory drug that exerts an anti-inflammatory effect by the induction of M2 macrophages through the use of activins.
Use of an anti-inflammatory steroid and a non-steroidal anti-inflammatory drug in the manufacture of a medicament for topical application to a joint of a patient.
Disclosed is an anti-inflammatory analgesic agent which is excellent in safety and has excellent anti-inflammatory effect and/or analgesic effect.
A pharmaceutical dosage form comprising a tablet containing a non-steroidal anti-inflammatory drug and misoprostol, wherein the non-steroidal anti-inflammatory drug is in the form of coated pellets.
The compounds of formula (I) have muscle relaxing, anti-inflammatory and anti-gout activity.
According to the present invention, the FADD inhibitor is anti-apoptotic, anti-inflammatory, or both.